Quarterly Call Option Transactions in Arbutus Biopharma Corp (ABUS)
This table provides information about the institutional ownership of Arbutus Biopharma Corp (ABUS) during . The information is specifically focused on institutions that hold call options of Arbutus Biopharma Corp.
Calls Purchased
Calls Sold
| Quarter | Buy | Sell | Net Activity | |||||
|---|---|---|---|---|---|---|---|---|
| New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
| Q2 2021 | 169,000 | 188,000 | 357,000 | 0 | 47,500 | 47,500 | 309,500 | |
| Q3 2021 | 1,192,500 | 528,060 | 1,720,560 | 69,500 | 0 | 69,500 | 1,651,060 | |
| Q4 2021 | 737,490 | 154,600 | 892,090 | 717,200 | 0 | 717,200 | 174,890 | |
| Q1 2022 | 225,000 | 24,200 | 249,200 | 213,800 | 568,900 | 782,700 | -533,500 | |
| Q2 2022 | 94,000 | 0 | 94,000 | 225,500 | 0 | 225,500 | -131,500 | |
| Q3 2022 | 15,000 | 100,100 | 115,100 | 496,700 | 0 | 496,700 | -381,600 | |
| Q4 2022 | 657,600 | 12,300 | 669,900 | 25,700 | 0 | 25,700 | 644,200 | |
| Q1 2023 | 254,400 | 183,500 | 437,900 | 377,700 | 0 | 377,700 | 60,200 | |
| Q2 2023 | 94,400 | 0 | 94,400 | 288,200 | 0 | 288,200 | -193,800 | |
| Q3 2023 | 50,000 | 11,100 | 61,100 | 133,400 | 0 | 133,400 | -72,300 | |
| Q4 2023 | 597,800 | 256,300 | 854,100 | — | 854,100 | |||
| Q1 2024 | 1,171,500 | 3,115,067 | 4,286,567 | 624,800 | 0 | 624,800 | 3,661,767 | |
| Q2 2024 | 50,000 | 0 | 50,000 | 1,191,300 | 0 | 1,191,300 | -1,141,300 | |